These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 20661231

  • 1. Immunomodulation by IFN-γ in patients with resistant infections and accompanying bronchiolitis obliterans following allo-SCT.
    Ammer J, Hahn J, Wolff D, Holler B, Landfried K, Hautmann A, Hamer OI, Schulz Ch, Hildebrandt G, Grube M, Andreesen R, Holler E.
    Bone Marrow Transplant; 2011 May; 46(5):756-8. PubMed ID: 20661231
    [No Abstract] [Full Text] [Related]

  • 2. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.
    Lucid CE, Savani BN, Engelhardt BG, Shah P, Clifton C, Greenhut SL, Vaughan LA, Kassim A, Schuening F, Jagasia M.
    Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT.
    Holm AM, Riise GC, Hansson L, Brinch L, Bjørtuft O, Iversen M, Simonsen S, Fløisand Y.
    Bone Marrow Transplant; 2013 May; 48(5):703-7. PubMed ID: 23064037
    [Abstract] [Full Text] [Related]

  • 5. Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation.
    Duncan CN, Buonanno MR, Barry EV, Myers K, Peritz D, Lehmann L.
    Bone Marrow Transplant; 2008 Jun; 41(11):971-5. PubMed ID: 18297116
    [Abstract] [Full Text] [Related]

  • 6. Tamibarotene for the Treatment of Bronchiolitis Obliterans Associated With Chronic Graft-vs-Host Disease.
    Watanabe S, Ishiyama K, Saeki K, Ohkura N, Kasahara K, Nakao S.
    Chest; 2019 Jan; 155(1):e1-e4. PubMed ID: 30616741
    [Abstract] [Full Text] [Related]

  • 7. Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation.
    Majhail NS, Schiffer CA, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):789-91. PubMed ID: 16785069
    [No Abstract] [Full Text] [Related]

  • 8. Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories.
    Sullivan KM, Shulman HM.
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):51-62. PubMed ID: 2662536
    [No Abstract] [Full Text] [Related]

  • 9. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
    Meng XJ, Lin MF, Cai Z.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Invasive airway aspergillosis with new airflow obstruction mimicking post-BMT bronchiolitis obliterans.
    Nusair S, Amir G, Or R, Breuer R.
    Bone Marrow Transplant; 2002 Apr; 29(8):711-3. PubMed ID: 12180119
    [Abstract] [Full Text] [Related]

  • 13. Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children.
    Nishio N, Yagasaki H, Takahashi Y, Muramatsu H, Hama A, Tanaka M, Yoshida N, Watanabe N, Kudo K, Yoshimi A, Kojima S.
    Bone Marrow Transplant; 2009 Sep; 44(5):303-8. PubMed ID: 19349954
    [Abstract] [Full Text] [Related]

  • 14. HBs seroconversion in a patient with acute hepatitis B treated with entecavir during immunosuppression against severe bronchiolitis obliterans in the course of chronic graft versus host disease.
    Christopeit M, Weber T, Abendroth J, Dollinger M, Lübbert C, Oehme A, Kekulé AS, Behre G.
    J Clin Virol; 2010 Jul; 48(3):218-9. PubMed ID: 20403727
    [Abstract] [Full Text] [Related]

  • 15. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation.
    Patriarca F, Skert C, Sperotto A, Damiani D, Cerno M, Geromin A, Zaja F, Stocchi R, Prosdocimo S, Fili' C, Fanin R.
    Bone Marrow Transplant; 2004 Apr; 33(7):751-8. PubMed ID: 14755316
    [Abstract] [Full Text] [Related]

  • 16. Failure of thalidomide to control bronchiolitis obliterans post bone marrow transplant.
    Heaton DC.
    Bone Marrow Transplant; 1989 Sep; 4(5):598. PubMed ID: 2790340
    [No Abstract] [Full Text] [Related]

  • 17. Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.
    Lorillon G, Robin M, Meignin V, Ribaud P, Lescoeur B, Gossot D, Socié G, Tazi A, Bergeron A.
    Eur Respir J; 2011 Aug; 38(2):470-2. PubMed ID: 21804164
    [No Abstract] [Full Text] [Related]

  • 18. Recipient interferon-gamma 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bogunia-Kubik K, Mlynarczewska A, Wysoczanska B, Lange A.
    Haematologica; 2005 Mar; 90(3):425-6. PubMed ID: 15749687
    [Abstract] [Full Text] [Related]

  • 19. Autologous blood pleurodesis for pneumothorax complicating graft-versus-host disease-related bronchiolitis obliterans.
    Chadwick C, Marven SM, Vora AJ.
    Bone Marrow Transplant; 2004 Feb; 33(4):451-3. PubMed ID: 14716352
    [Abstract] [Full Text] [Related]

  • 20. [Association between acute graft versus host disease and lung injury after allogenic hematopoietic stem cell transplantation].
    Liu QF, Luo XD, Fan ZP, Ning J, Xu D, Sun J, Zhang Y, Xu B, Wei YQ.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 03; 89(8):538-42. PubMed ID: 19567075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.